-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gavorestat in Galactosemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gavorestat in Galactosemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gavorestat in Galactosemia Drug Details: Govorestat (AT-007) is under development for the...
-
Company Profile
Applied Therapeutics Inc – Company Profile
Applied Therapeutics Inc (Applied Therapeutics) is a clinical-stage biopharmaceutical company that discovers and develops transformative drugs in areas of Galactosemia and Diabetic Cardiomyopathy (DbCM). The company product pipeline includes include AT-001 a novel aldose reductase inhibitor, AT-007 a SORD Deficiency, AT-001 a Diabetic Peripheral Neuropathy. Applied Therapeutics also develops preclinical pipeline product AT-003, an ARI designed for the treatment of diabetic retinopathy and AT-104 a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukaemia. It serves customers...
Add to Basket -
Product Insights
Net Present Value Model: Gavorestat
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Gavorestat Drug Details Govorestat (AT-007) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – gavorestat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry gavorestat Drug Details Govorestat (AT-007) is under development for the treatment of galactosemia in...